Metraipolis › archive › dc_53ff72df59ef

Case Report: Trametinib in the treatment of patients with metastatic lung adenocarcinoma harboring NF1 mutation: a case series and literature review — Europe PMC PMID:41170454

Source: Europe PMC (en)
Original: https://europepmc.org/article/MED/41170454
DOI: 10.3389/fonc.2025.1481284
License (as archived): solo-consultazione
Archived: 2026-11-09T07:30:23.062Z
SHA-256 of the archived text: cf9b1cd9ef3a617b99b64140d410c3938572228942e4472d4283030b8f522daa
Stable URL of this page: https://metraipolis.com/documento/dc_53ff72df59ef

How to cite

Case Report: Trametinib in the treatment of patients with metastatic lung adenocarcinoma harboring NF1 mutation: a case series and literature review — Europe PMC PMID:41170454 — Europe PMC (en), https://europepmc.org/article/MED/41170454 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_53ff72df59ef (Metraipolis archive dc_53ff72df59ef, sha256 cf9b1cd9ef3a617b99b64140d410c3938572228942e4472d4283030b8f522daa)

BibTeX

@misc{dc53ff72df59ef,
  title = {Case Report: Trametinib in the treatment of patients with metastatic lung adenocarcinoma harboring NF1 mutation: a case series and literature review — Europe PMC PMID:41170454},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41170454},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_53ff72df59ef; sha256 cf9b1cd9ef3a617b99b64140d410c3938572228942e4472d4283030b8f522daa},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41170454. Agents can read the archived copy with the MCP tool read_document.